Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus.

Raymond J Davey, Timothy W Jones, Paul A Fournier
Author Information
  1. Raymond J Davey: School of Sport Science, Exercise and Health, University of Western Australia, Crawley, Western Australia, Australia. daveyr01@student.uwa.edu.au

Abstract

BACKGROUND: The objective of this study was to examine whether setting the low glucose alarm of a Guardian® REAL-Time continuous glucose monitoring system (CGMS) to 80 mg/dl for 3 days and providing instructions to users reduce the risk of hypoglycemia under free-living conditions in individuals with type 1 diabetes mellitus (T1DM).
METHODS: Fourteen participants with T1DM aged 26.1±6.0 years (mean±standard deviation) were fitted with a CGMS and assigned for 3 days to either an alarm [low and high blood glucose (BG) alarms set at 80 and 200 mg/dl, respectively] or no alarm condition, with each treatment administered to all participants following a counterbalanced design. All participants were given detailed instructions on how to respond appropriately to low glucose alarms.
RESULTS: The CGMS with alarm reduced the incidence of hypoglycemia (CGMS readings≤65 mg/dl) by 44% as well as the time spent below this hypoglycemic threshold by 64% without increasing average BG levels. However, the CGMS with alarm had no effect on the incidence of symptomatic hypoglycemia.
CONCLUSIONS: Short-term use of the CGMS with alarm, together with appropriate instructions for users, reduces the incidence and duration of hypoglycemia, but only to a limited extent, in part because it overestimates BG in the low glucose range.

References

  1. Diabetes Technol Ther. 2005 Jun;7(3):440-7 [PMID: 15929675]
  2. Diabetes Care. 1987 Sep-Oct;10(5):622-8 [PMID: 3677983]
  3. Diabetes Care. 2004 Aug;27(8):1922-8 [PMID: 15277418]
  4. Manag Care. 2008 Aug;17(8):40-5 [PMID: 18777789]
  5. Diabetes Technol Ther. 2009 Mar;11(3):145-50 [PMID: 19216686]
  6. Pediatrics. 2003 Apr;111(4 Pt 1):790-4 [PMID: 12671113]
  7. Diabetes Technol Ther. 2003;5(1):27-31 [PMID: 12725704]
  8. Diabetes Technol Ther. 2001 Fall;3(3):357-65 [PMID: 11762514]
  9. Diabetes Metab. 2003 Apr;29(2 Pt 1):159-62 [PMID: 12746637]
  10. Diabetes. 2003 Nov;52(11):2790-4 [PMID: 14578298]
  11. Pediatrics. 2001 Feb;107(2):222-6 [PMID: 11158450]
  12. Diabetes Care. 2006 Dec;29(12):2730-2 [PMID: 17130215]
  13. Horm Metab Res. 1997 Mar;29(3):92-6 [PMID: 9137976]
  14. Diabetes Care. 2003 Apr;26(4):1153-7 [PMID: 12663589]
  15. Diabetes Care. 2000 Aug;23(8):1143-8 [PMID: 10937512]
  16. J Pediatr (Rio J). 2005 Jul-Aug;81(4):293-7 [PMID: 16106313]
  17. Diabetes Technol Ther. 2006 Apr;8(2):146-55 [PMID: 16734545]
  18. Diabetes Care. 2006 Jan;29(1):44-50 [PMID: 16373894]
  19. N Engl J Med. 2008 Oct 2;359(14):1464-76 [PMID: 18779236]
  20. Diabet Med. 2003 Mar;20(3):238-41 [PMID: 12675670]
  21. Diabetologia. 1996 May;39(5):609-12 [PMID: 8739922]
  22. Diabetologia. 1994 Dec;37(12):1265-76 [PMID: 7895957]
  23. Diabet Med. 2003 Dec;20(12):1012-5 [PMID: 14632702]
  24. Diabetes Metab Res Rev. 2002 Jul-Aug;18(4):324-9 [PMID: 12203948]
  25. Diabetes Care. 2002 May;25(5):889-93 [PMID: 11978686]
  26. Pol Arch Med Wewn. 2005 Oct;114(4):953-7 [PMID: 16789520]
  27. Diabetes Care. 2005 Dec;28(12):2871-6 [PMID: 16306547]
  28. Diabetes Care. 2002 Feb;25(2):275-8 [PMID: 11815495]
  29. Clin Chem. 1993 Apr;39(4):561-77 [PMID: 8472349]
  30. Diabetes Technol Ther. 2008 Apr;10(2):69-80 [PMID: 18260770]
  31. Diabetes Technol Ther. 2004 Apr;6(2):105-13 [PMID: 15117576]
  32. Am J Physiol. 1988 Aug;255(2 Pt 1):E218-20 [PMID: 3407771]
  33. Am J Physiol. 1999 Sep;277(3):E561-71 [PMID: 10484370]
  34. Diabetes Care. 2003 Mar;26(3):582-9 [PMID: 12610005]
  35. Diabetes Technol Ther. 2003;5(5):781-9 [PMID: 14633343]
  36. Diabetes Care. 2004 Mar;27(3):734-8 [PMID: 14988294]
  37. Mayo Clin Proc. 2004 Dec;79(12):1521-6 [PMID: 15595336]
  38. Anal Chem. 1996 Nov 1;68(21):3822-6 [PMID: 8914483]
  39. Diabetes Care. 2001 May;24(5):881-5 [PMID: 11347748]
  40. Diabetes Technol Ther. 2009 Feb;11(2):65-72 [PMID: 19243265]
  41. Diabetes Care. 2008 Nov;31(11):2110-2 [PMID: 18694975]
  42. Diabetes Care. 2006 Dec;29(12):2644-9 [PMID: 17130198]
  43. Diabetes Care. 2001 Nov;24(11):1858-62 [PMID: 11679447]
  44. Diabetes Care. 2002 Sep;25(9):1499-503 [PMID: 12196417]
  45. Diabetes Care. 2003 Mar;26(3):662-7 [PMID: 12610018]
  46. Diabetes Metab. 2007 Nov;33(5):360-5 [PMID: 17652003]
  47. Diabetologia. 2005 Sep;48(9):1833-40 [PMID: 16001232]
  48. Diabetes Care. 2007 Jan;30(1):59-64 [PMID: 17192334]
  49. Diabetes Metab. 2003 Dec;29(6):608-12 [PMID: 14707890]

MeSH Term

Adult
Biomarkers
Blood Glucose
Clinical Alarms
Diabetes Mellitus, Type 1
Female
Glycated Hemoglobin
Humans
Hypoglycemia
Hypoglycemic Agents
Incidence
Insulin
Male
Monitoring, Ambulatory
Predictive Value of Tests
Time Factors
Treatment Outcome
Western Australia
Young Adult

Chemicals

Biomarkers
Blood Glucose
Glycated Hemoglobin A
Hypoglycemic Agents
Insulin
hemoglobin A1c protein, human

Word Cloud

Created with Highcharts 10.0.0glucosealarmCGMShypoglycemialowincidencemg/dlinstructionsparticipantsBGsettingcontinuousmonitoringsystem803daysuserstype1diabetesmellitusT1DMalarmsusedurationBACKGROUND:objectivestudyexaminewhetherGuardian®REAL-Timeprovidingreduceriskfree-livingconditionsindividualsMETHODS:Fourteenaged261±60yearsmean±standarddeviationfittedassignedeither[lowhighbloodset200respectively]conditiontreatmentadministeredfollowingcounterbalanceddesigngivendetailedrespondappropriatelyRESULTS:reducedreadings≤6544%welltimespenthypoglycemicthreshold64%withoutincreasingaveragelevelsHowevereffectsymptomaticCONCLUSIONS:Short-termtogetherappropriatereduceslimitedextentpartoverestimatesrangeEffectshort-termreal-timedisplayhome

Similar Articles

Cited By